Eisai kicks off mid-stage study of sleep drug

Eisai has kicked off a mid-stage study assessing its potential first-in-class experimental therapy lemborexant in Alzheimer's patients with Irregular Sleep-Wake Rhythm Disorder (ISWRD).
Read the full story: PharmaTimes: News RSS